Skip to main navigation Skip to search Skip to main content

Change in KDIGO Kidney Risk Category with Semaglutide Treatment – A Post-Hoc Analysis of the Sustain 6 Trial

Research output: Other contribution

Original languageUndefined/Unknown
StatePublished - Jan 1 2022

Publication series

NameArticles, Abstracts, and Reports

Cite this